Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter.

Elefantova K, Lakatos B, Kubickova J, Sulova Z, Breier A.

Int J Mol Sci. 2018 Jul 7;19(7). pii: E1985. doi: 10.3390/ijms19071985.

2.

Association study between ABCB1, ABCB6 and ABCG1 polymorphisms and major depressive disorder in the Chinese Han population.

Ma G, Huang X, Bi Y, Ren D, Xu F, Sun Q, Zhang R, Hu J, Niu W, Guo Z, Yuan R, Yuan F, Wu X, Cao Y, Yang F, Wang L, Li W, Yu T, He L, Liu J, He G, Li X.

Psychiatry Res. 2018 May 23. pii: S0165-1781(17)31767-5. doi: 10.1016/j.psychres.2018.05.045. [Epub ahead of print] No abstract available.

PMID:
29929738
3.

Does G2677T Polymorphism of the MDR1 Gene Make a Difference in the Therapeutic Response to Paroxetine in Depressed Patients in a Slovakian Population?

Vancova Z, Cizmarikova M, Dragasek J, Zofcakova S, Kolarcik P, Mojzis J.

Med Sci Monit. 2018 May 13;24:3136-3145. doi: 10.12659/MSM.907434.

4.

Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females.

Rahikainen AL, Palo JU, Haukka J, Sajantila A.

Pharmacogenet Genomics. 2018 Apr;28(4):99-106. doi: 10.1097/FPC.0000000000000328.

PMID:
29481489
5.

Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Amare AT, Schubert KO, Baune BT.

EPMA J. 2017 Sep 5;8(3):211-227. doi: 10.1007/s13167-017-0112-8. eCollection 2017 Sep. Review.

6.

L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins.

Pavlikova L, Seres M, Hano M, Bohacova V, Sevcikova I, Kyca T, Breier A, Sulova Z.

Molecules. 2017 Jul 3;22(7). pii: E1104. doi: 10.3390/molecules22071104.

7.

Multiple drug transporters mediate the placental transport of sulpiride.

Bai M, Ma Z, Sun D, Zheng C, Weng Y, Yang X, Jiang T, Jiang H.

Arch Toxicol. 2017 Dec;91(12):3873-3884. doi: 10.1007/s00204-017-2008-8. Epub 2017 Jun 9.

PMID:
28597291
8.

Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.

Peterson K, Dieperink E, Anderson J, Boundy E, Ferguson L, Helfand M.

Psychopharmacology (Berl). 2017 Jun;234(11):1649-1661. doi: 10.1007/s00213-017-4622-9. Epub 2017 Apr 29. Review.

PMID:
28456840
9.

Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway.

Wang H, Wang X, Liao A, Liu Z.

Mol Cell Biochem. 2017 Sep;433(1-2):141-148. doi: 10.1007/s11010-017-3022-0. Epub 2017 Apr 12.

PMID:
28405849
10.

[Genetic tests for controlling treatment with antidepressants].

Bschor T, Baethge C, Hiemke C, Müller-Oerlinghausen B.

Nervenarzt. 2017 May;88(5):495-499. doi: 10.1007/s00115-017-0310-6. Review. German.

PMID:
28303314
11.

Gene expression and proliferation biomarkers for antidepressant treatment resistance.

Breitfeld J, Scholl C, Steffens M, Laje G, Stingl JC.

Transl Psychiatry. 2017 Mar 14;7(3):e1061. doi: 10.1038/tp.2017.16.

12.

P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine.

Liao MZ, Gao C, Shireman LM, Phillips B, Risler LJ, Neradugomma NK, Choudhari P, Prasad B, Shen DD, Mao Q.

Pharmacol Res. 2017 May;119:61-71. doi: 10.1016/j.phrs.2017.01.018. Epub 2017 Jan 19.

13.

Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder.

Ozbey G, Celikel FC, Cumurcu BE, Kan D, Yucel B, Hasbek E, Percin F, Guzey IC, Uluoglu C.

Nord J Psychiatry. 2017 Apr;71(3):230-237. doi: 10.1080/08039488.2016.1268203. Epub 2017 Jan 12.

PMID:
28079463
14.

ABCB1 genotyping in the treatment of depression.

Brückl TM, Uhr M.

Pharmacogenomics. 2016 Dec;17(18):2039-2069. Epub 2016 Dec 5. Review.

PMID:
27918249
15.

Pharmacogenetic studies: a tool to improve antidepressant therapy.

Ramos M, Berrogain C, Concha J, Lomba L, García CB, Ribate MP.

Drug Metab Pers Ther. 2016 Dec 1;31(4):197-204. doi: 10.1515/dmpt-2016-0019. Review.

PMID:
27889704
16.

Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy.

Breitfeld J, Scholl C, Steffens M, Brandenburg K, Probst-Schendzielorz K, Efimkina O, Gurwitz D, Ising M, Holsboer F, Lucae S, Stingl JC.

Transl Psychiatry. 2016 Nov 15;6(11):e950. doi: 10.1038/tp.2016.185.

17.
18.

Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.

Lett TA, Walter H, Brandl EJ.

CNS Drugs. 2016 Dec;30(12):1169-1189. Review.

PMID:
27752945
19.

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response.

Fabbri C, Hosak L, Mössner R, Giegling I, Mandelli L, Bellivier F, Claes S, Collier DA, Corrales A, Delisi LE, Gallo C, Gill M, Kennedy JL, Leboyer M, Lisoway A, Maier W, Marquez M, Massat I, Mors O, Muglia P, Nöthen MM, O'Donovan MC, Ospina-Duque J, Propping P, Shi Y, St Clair D, Thibaut F, Cichon S, Mendlewicz J, Rujescu D, Serretti A.

World J Biol Psychiatry. 2017 Feb;18(1):5-28. doi: 10.1080/15622975.2016.1208843. Epub 2016 Sep 7. Review.

PMID:
27603714
20.

One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms.

Blázquez A, Gassó P, Mas S, Plana MT, Lafuente A, Lázaro L.

Pharmacopsychiatry. 2016 Nov;49(6):248-253. Epub 2016 Jun 16.

PMID:
27309038

Supplemental Content

Loading ...
Support Center